文献速递炎症性肠病

炎症性肠病观察性研究中的混杂与偏倚:一项元流行病学研究

Confounding and bias in observational studies in inflammatory bowel disease: a meta-epidemiological study.
PubMed 文献 · Aliment Pharmacol Ther · 2020-12-09

该研究随机抽取160篇发表于高影响力胃肠病学期刊的炎症性肠病观察性研究,评估混杂与偏倚的报告情况。结果显示仅41.9%提及混杂、55.6%报告偏倚,37.5%讨论主要发现是否受影响,4.4%呼吁谨慎解读。提及混杂与年引用量正相关(P=0.010)。

要点

  • 仅41.9%的文献提及混杂,55.6%报告偏倚,报告明显不足。
  • 仅37.5%讨论混杂对主要发现的影响,4.4%呼吁谨慎解读。
  • 提及混杂与年引用量正相关(P=0.010),但呼吁谨慎解读无此关联。

核心结论

  • 炎症性肠病高影响力观察性研究中混杂报告不足,其影响在解读时常被忽视。
  • 提及混杂与年引用量正相关(P=0.010),而呼吁谨慎解读与引用量无关。

研究设计与样本

  • 元流行病学研究,随机抽取160篇发表于高影响力胃肠病学期刊的炎症性肠病观察性研究。
  • 采用标准化方法评估混杂与偏倚的报告和讨论,并用混合效应多变量回归分析年引用量与研究特征的关联。

主要发现

  • 160篇中67篇(41.9%)提及混杂,89篇(55.6%)报告任何偏倚。
  • 139篇(86.9%)应用减少混杂或偏倚的策略,116篇(72.5%)承认至少一个未调整混杂因素。
  • 60篇(37.5%)评论主要发现是否可能受影响,仅7篇(4.4%)在讨论中呼吁谨慎解读结果。
  • 病例对照研究、非常规收集数据、以实验室分析为主要方法及研究不可改变暴露的研究报告尤其缺乏。

临床怎么用

  • 解读炎症性肠病观察性研究时,需仔细评估混杂与偏倚的后果。
  • 临床参考此类研究结论时应关注作者是否讨论混杂对主要发现的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Observational research concerning inflammatory bowel disease (IBD) is highly susceptible to spurious findings because of confounding and bias. AIM: To investigate how these issues were reported in this research field. METHODS: We identified and appraised a random sample of 160 observational studies concerning IBD published in high-impact gastroenterology journals and the most respected specialty journals of the condition. We applied a standardised methodology to assess how confounding and bias were reported and discussed, and investigated the association between yearly citations and study characteristics using mixed-effect multivariable regression analysis. RESULTS: The authors of 67 out of 160 articles (41.9%) mentioned confounding, and in 89 cases (55.6%) reported any bias. Although most authors applied strategies to minimise confounding or bias (n = 139; 86.9%) and acknowledged at least one unadjusted confounder (n = 116; 72.5%), a minority commented about whether the main findings could have been affected (n = 60; 37.5%). Very few authors (n = 7; 4.4%) called for caution in interpreting the results in the discussion. Reporting of confounding and bias was particularly lacking for case-control studies, those not using routinely collected data, those employing laboratory analyses as the primary method of assessment and studies investigating non-modifiable exposures. In adjusted analyses, mentioning or alluding to confounding was positively associated with yearly citations (P = 0.010), whereas calling for a cautious interpretation of the findings was not. CONCLUSIONS: Reporting of confounding is inadequate and its acknowledgement is often neglected in interpreting high-impact observational research in IBD. These results encourage a more careful evaluation of the consequences of confounding and bias.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Piovani D, Pansieri C, Peyrin-Biroulet L, et al. Confounding and bias in observational studies in inflammatory bowel disease: a meta-epidemiological study. Aliment Pharmacol Ther. 2020. PMID: 33296517. doi:10.1111/apt.16222

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。